NYSE:NUS - New York Stock Exchange, Inc. - US67018T1051 - Common Stock - Currency: USD
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Nu Skin's stock rose premarket on Friday following the announcement of its Rhyz subsidiary selling the Mavely platform to Later for $250 million.
Personal care company Nu Skin (NYSE:NUS) reported Q4 CY2024 results topping the market’s revenue expectations, but sales fell by 8.8% year on year to $445.6 million. On the other hand, next quarter’s revenue guidance of $355 million was less impressive, coming in 12.3% below analysts’ estimates. Its non-GAAP profit of $0.38 per share was 72.3% above analysts’ consensus estimates.
Personal care company Nu Skin (NYSE:NUS) will be reporting earnings tomorrow after the bell. Here’s what investors should know.
Nu Skin Enterprises, Inc. (NYSE:NUS) saw its shares rise on Friday following the announcement of a strategic transaction by its Rhyz Inc. subsidiary. Rhyz has sold its Mavely affiliate marketing technology platform to Later, a portfolio company of Summit Partners, for approximately $250 million in cash and a minority equity stake in the combined Later/Mavely business. The deal, which also includes $33 million to be paid to other equity holders in the Mavely business, is part of Nu Skin’s broader
/PRNewswire/ -- Later, a leader in influencer marketing and social media management software and services, today announced its acquisition of Mavely, the...